From its beginnings as an entity on the medical fringe, fibromyalgia has now gained recognition as a distinct disease to the point where the FDA has approved the first drug specifically for its treatment. But while patients can be reassured that they are not “imagining things,” diagnosis and management continue to pose major challenges.